Methods of inhibiting ectopic calcification

Details Methods of inhibiting ectopic calcification Methods of inhibiting ectopic calcification

2003-02-26

2008-09-02

Kemmerer, Elizabeth C. (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S085100, C424S093210, C435S325000

Reexamination Certificate

active

07419950

ABSTRACT:
The invention provides a method of inhibiting ectopic calcification in an individual. The method consists of administering to the individual a therapeutically effective amount of osteopontin or a functional fragment thereof.

REFERENCES:
patent: 5340934 (1994-08-01), Termine et al.
patent: 5695761 (1997-12-01), Denhardt et al.
patent: 5824651 (1998-10-01), Nanci et al.
patent: 5843781 (1998-12-01), Ballermann et al.
patent: 6001350 (1999-12-01), Mulligan et al.
patent: 0 705 842 (1996-04-01), None
patent: WO 92/22316 (1992-12-01), None
Salacinski HJ, Tiwari A, Hamilton G, Seifalian AM. Cellular engineering of vascular bypass grafts: role of chemical coatings for enhancing endothelial cell attachment. Med Biol Eng Comput. Nov. 2001; 39(6):609-18. Abstract.
Sipehia R, Martucci G, Lipscombe J. Transplantation of human endothelial cell monolayer on artificial vascular prosthesis. Artif Cells Blood Substit Immobil Biotechnol. Jan. 1996; 24(1):51-63. Abstract.
Vohra R, Thomson GJL, Carr HMH, Sharma H, Walker MG. Comparison of different vascular prostheses and matrices in relation to endothelial seeding. Br. J. Surg. Apr. 1991; 78:417-420.
Barisoni et al., “Osteopontin (OP) mRNA and Protein Expression in Glomerular Disease (GD) Correlates with Tubulo-Interstitial Damage (TID)”J. Am. Soc. NephrolAbstract A2523, 7:1751 (1996).
Bautista et al., “A monoclonal antibody against Osteopontin inhibits RGD-mediated cell adhesion to osteopontin.”Annals New York Academy Sciences, 760:309-311 (1995).
Bautista et al., “Low-Molecular-Weight Variants of Osteopontin Generated by Serine Proteinases in Urine of Patients With Kidney Stones”J. of Cellular Biochemistry61:402-409 (1996).
Bautista et al., “Quantification of Osteopontin in Human Plasma With an ELISA: Basal Levels in Pre- and Postmenopausal Women”Clinical Biochemistry29(3):231-239 (1996).
Boskey, Adele L., “Matrix Proteins and Mineralization: An Overview”,Connective Tissue Research, 35(1-4):357-363[411-417], (1996).
Boskey et al., “Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel”,Bone and Mineral, 22:147-159 (1993).
Butler et al., “Osteopontin”,Principles of Bone Biology, 13:167-181 (1996).
Chen et al., “Calcium and Collagen Binding Properties of Osteopontin, Bone Sialoprotein, and Bone Acidic Glycoprotein-75 from Bone”,The Journal of Biological Chemistry, 267(34):24871-24878 (1992).
Daoud et al., “Sequential Morphologic Studies of Regression of Advanced Atherosclerosis,”Arch. Pathol. Lab. Med. 105:233-239 (1981).
Diamond et al., “Early and Persistent Up-Regulated Expression of Renal Cortical Osteopontin in Experimental Hydronephrosis”Am. J. of Pathology146(6):1455-1466 (1995).
Fitzpatrick, et al., “Diffuse Calcification in Human Coronary Arteries”,The Journal of Clinical Investigation, Inc., 94:1597-1604 (1994).
Giachelli et al., “Osteopontin Is Elevated during Neointima Formation in Rat Arteries and Is a Novel Component of Human Atherosclerotic Plaques”,J. Clin. Invest., 92:1686-1696 (1993).
Giachelli et al., “Molecular and Cellular Biology of Osteopontin”,TCM, 5(3):88-95 (1995).
Giachelli et al., “Osteopontin: Potential Roles in Vascular Function and Dystrophic Calcification”,J. Bone Miner Metab, 15:179-183 (1997).
Giachelli et al., “Evidence for a Role of Osteopontin in Macrophage Infiltration in Response to Pathological Stimuli in Vivo,”Amer. J. Pathology152(2):353-358 (1998).
Hirota et al., “Expression of Osteopontin Messenger RNA by Macrophages in Atherosclerotic Plaques”,American Journal of Pathology, 143(4):1003-1008 (1993).
Hunter et al., “Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation”,Biochem J., 300:723-728 (1994).
Ikeda et al., “Osteopontin mRNA Is Expressed by Smooth Muscle-derived Foam Cells is Human Atherosclerotic Lesions of the Aorta”,J. Clin. Invest., 92:2814-2820 (1993).
Khanna et al., “Captopril Prevents Increased Urinary and Renal Cortical Osteopontin in Stroke-Prone Spontaneously Hypertensive Rats”J. Am. Soc. Nephrol. Abstract A2452, 7:1737 (1996).
Kiefer et al., “The cDNA and derived amino acid sequence for human osteopontin”,Nucleic Acids Research, 17(8) (1989).
Kim et al., “Dual Mechanisms for the Low Plasma Levels of Truncated Apolipoprotein B Proteins in Familial Hypobetalipoproteinemia”,J. Clin. Invest., 101(6):1468-1477 (1998).
Kleinman et al., “Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney”Kidney International47:1585-1596 (1995).
Kleinman et al., “Upregulation of Osteopontin Expression by Ischemia in Rat Kidney”Annals New York Academy of Sciences760:321-323 (1995).
Liang and Barnes, “Renal expression of osteopontin and alkaline phosphatase correlates with BUN levels in aged rats”Am. J. Physiol.269:F398-F404 (1995).
Liaw et al., “Neutralizing Antibodies Directed Against Osteopontin Inhibit Rat Carotid Neointimal Thickening After Endothelial Denudation”,Arteriosclerosis, Thrombosis, and Vascular Biology, 17(1):188-193 (1997).
Liaw et al., “Osteopontin and β3Integrin Are Coordinately Expressed in Regenerating Endothelial In Vivo and Stimulate Arg-Gly-Asp-Dependent Endothelial Migration In Vitro”,Circulation Research, 77(4):665-672 (1995).
Liaw et al., “Osteopontin Promotes Vascular Cell Adhesion and Spreading and is Chemotactic for Smooth Muscle Cells In Vitro”,Circulation Research, 74(2):214-224 (1994).
Liaw et al., “The Adhesive and Migratory Effects of Osteopontin Are Mediated via Distinct Cell Surface Integrins”,J. Clin. Invest., 95:713-724 (1995).
Liaw et al., “Altered Wound Healing in Mice Lacking a Functional Osteopontin Gene (spp1)”,J. Clin. Invest., 101(7):1468-1478 (1998).
Magil et al., “Osteopontin in chronic puromycin aminonucleoside nephrosis.”J. Amer. Society Nephrology, 8:1383-1390 (1997).
McKee and Nanci, “Osteopontin at Mineralized Tissue Interfaces in Bone, Teeth, and Osseointegrated Implants: Ultrastructural Distribution and Implications for Mineralized Tissue Formation, Turnover, and Repair”,Microscopy Research and Technique, 33:141-164 (1996).
McKee and Nanci, “Secretion of Osteopontin by Macrophages and Its Accumulation at Tissue Surfaces During Wound Healing in Mineralized Tissues: A Potential Requirement for Macrophage Adhesion and Phagocytosis”,The Anatomical Record, 245:394-409 (1996).
McKee and Nanci, “Osteopontin: an Interfacial Extracellular Matrix Protein in Mineralized Tissues.”Connective Tissue Research, Vo.35(1-4):197-205[251-259] (1996).
Murry et al., “Macrophages Express Osteopontin During Repair of Myocardial Necrosis,”Amer. J. Pathology145(6):1450-1462 (1994).
O'Brien et al., “Osteopontin Is Expressed in Human Aortic Valvular Lesions”,Circulation, vol. 92(8):2163-2168 (1995).
O'Brien et al., “Osteopontin Is Synthesized by Macrophage, Smooth Muscle,a nd Endothelial Cells in Promary and Restenotic Human Coronary Atherosclerotic Plaques”,Arterisclerosis and Thrombosis, 14:1648-1656 (1994).
Pichler et al., “Pathogenesis of Cyclosporine Nephropathy: Roles of Angiotensin II and Osteopontin”J. Am. Soc. Nephrol. 6(4):1186-1196 (1995).
Ross et al., “Interactions between the Bone Matrix Proteins Osteopontin ad Bone Sialoprotein and the Osteoclast Integrin αvβ3Potentiate Bone Resorption”,The Journal of Biological Chemistry, 268:9901-9907 (1993).
Shen et al., “Ostepontin is Associated with Bioprosthetic Heart Valve Calcification in Humans”,C.R. Acad. Sci., 320:49-57 (1997).
Shiraga et al., “Inhibition of calcium oxal

Affiliated with

Also associated with

Rating

Methods of inhibiting ectopic calcification does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of inhibiting ectopic calcification, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting ectopic calcification will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3972433